Augmented TLR9-induced Btk activation in PIR-B–deficient B-1 cells provokes excessive autoantibody production and autoimmunity

Pathogens are sensed by Toll-like receptors (TLRs) expressed in leukocytes in the innate immune system. However, excess stimulation of TLR pathways is supposed to be connected with provocation of autoimmunity. We show that paired immunoglobulin (Ig)-like receptor B (PIR-B), an immunoreceptor tyrosine-based inhibitory motif–harboring receptor for major histocompatibility class I molecules, on relatively primitive B cells, B-1 cells, suppresses TLR9 signaling via Bruton's tyrosine kinase (Btk) dephosphorylation, which leads to attenuated activation of nuclear factor κB p65RelA but not p38 or Erk, and blocks the production of natural IgM antibodies, including anti-IgG Fc autoantibodies, particularly rheumatoid factor. The autoantibody production in PIR-B–deficient (Pirb−/−) mice was further augmented in combination with the Faslpr mutation, which might be linked to the development of autoimmune glomerulonephritis. These results show the critical link between TLR9-mediated sensing and a simultaneously evoked, PIR-B–mediated inhibitory circuit with a Btk intersection in B-1 cells, and suggest a novel way toward preventing pathogenic natural autoantibody production.

[1]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.

[2]  Hong Zhang,et al.  The Inhibitory Receptor PIR-B Negatively Regulates Neutrophil and Macrophage Integrin Signaling1 , 2004, The Journal of Immunology.

[3]  R. Hardy,et al.  Rheumatoid factor secretion from human Leu-1+ B cells. , 1987, Science.

[4]  A. Nakamura,et al.  Exacerbated graft-versus-host disease in Pirb−/− mice , 2004, Nature Immunology.

[5]  Kenneth G. C. Smith,et al.  Interleukin 4 Reduces Expression of Inhibitory Receptors on B Cells and Abolishes CD22 and FcγRII-mediated B Cell Suppression , 2002, The Journal of experimental medicine.

[6]  E. Montecino-Rodriguez,et al.  New perspectives in B-1 B cell development and function. , 2006, Trends in immunology.

[7]  T. Takai,et al.  Molecular Cloning of a Novel Murine Cell-surface Glycoprotein Homologous to Killer Cell Inhibitory Receptors* , 1997, The Journal of Biological Chemistry.

[8]  D. Isenberg,et al.  The relationship between CD5-expressing B lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives. , 1990, Arthritis and rheumatism.

[9]  A. Nakamura,et al.  Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation , 2007, The Journal of experimental medicine.

[10]  F. Spertini,et al.  Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice. , 1987, Journal of immunology.

[11]  R. Eisenberg,et al.  Circulating anti-DNA-rheumatoid factor complexes in MRL/1 mice. , 1980, Clinical immunology and immunopathology.

[12]  C. Feighery,et al.  Signaling by Toll-like Receptors 8 and 9 Requires Bruton's Tyrosine Kinase* , 2007, Journal of Biological Chemistry.

[13]  R. Berland,et al.  Origins and functions of B-1 cells with notes on the role of CD5. , 2002, Annual review of immunology.

[14]  Felicia A Tucci,et al.  Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses. , 2006, Rheumatology.

[15]  R. Zinkernagel,et al.  Control of early viral and bacterial distribution and disease by natural antibodies. , 1999, Science.

[16]  C. Mackay,et al.  BAFF and MyD88 signals promote a lupuslike disease independent of T cells , 2007, The Journal of experimental medicine.

[17]  M. Shlomchik,et al.  Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.

[18]  Xuetao Cao,et al.  Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1 , 2008, Nature Immunology.

[19]  Wolfgang Weninger,et al.  Negative Regulation of TLR-Signaling Pathways by Activating Transcription Factor-31 , 2007, The Journal of Immunology.

[20]  R. Hardy B-1 B cells: development, selection, natural autoantibody and leukemia. , 2006, Current opinion in immunology.

[21]  Biochemical Nature and Cellular Distribution of the Paired Immunoglobulin-like Receptors, PIR-A and PIR-B , 1999, The Journal of experimental medicine.

[22]  D. Walls,et al.  Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus , 2007, Journal of Virology.

[23]  T. Honjo,et al.  Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. , 1995, International immunology.

[24]  M. Cooper,et al.  A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  V. Holers,et al.  Innate autoimmunity. , 2005, Advances in immunology.

[26]  M. Welham,et al.  Molecular interactions of SHP1 and SHP2 in IL-3-signalling. , 2002, Cellular signalling.

[27]  L. Genestier,et al.  TLR Agonists Selectively Promote Terminal Plasma Cell Differentiation of B Cell Subsets Specialized in Thymus-Independent Responses1 , 2007, The Journal of Immunology.

[28]  S. Akira,et al.  Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.

[29]  M. Kopf,et al.  Toll-like receptors: paving the path to T cell-driven autoimmunity? , 2007, Current opinion in immunology.

[30]  B. Beutler,et al.  TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity , 2007, Nature Medicine.

[31]  B. Pulendran,et al.  Toll-Like Receptor Expression and Responsiveness of Distinct Murine Splenic and Mucosal B-Cell Subsets , 2007, PloS one.

[32]  A. Nakamura,et al.  Impaired dendritic cell maturation and increased TH2 responses in PIR-B−/− mice , 2002, Nature Immunology.

[33]  G. Lemke,et al.  TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response , 2007, Cell.

[34]  C. Chen,et al.  Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Newkirk Rheumatoid factors: host resistance or autoimmunity? , 2002, Clinical immunology.

[36]  R. Lovering,et al.  Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis. , 1994, Human molecular genetics.

[37]  E. Wong,et al.  Bruton's Tyrosine Kinase Separately Regulates NFκB p65RelA Activation and Cytokine Interleukin (IL)-10/IL-12 Production in TLR9-stimulated B Cells* , 2008, Journal of Biological Chemistry.

[38]  M. Clare-Salzler,et al.  Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases , 2009 .

[39]  A. Nakamura,et al.  FcγRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease , 2003, European journal of immunology.

[40]  Hong Zhang,et al.  The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B. , 2005, Immunity.

[41]  A. Krieg,et al.  Toll‐like receptors 7, 8, and 9: linking innate immunity to autoimmunity , 2007, Immunological reviews.

[42]  J. Kinet,et al.  Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1 , 1999, Oncogene.

[43]  L. Herzenberg,et al.  Unraveling B-1 progenitors. , 2007, Current opinion in immunology.

[44]  T. Kunikata,et al.  Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. , 1996, Blood.

[45]  H. Zola,et al.  Evaluation of CD5-positive B cells in blood and synovial fluid of patients with rheumatic diseases , 2004, Rheumatology International.

[46]  L. Herzenberg,et al.  Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion , 2005, Springer Seminars in Immunopathology.